You have 9 free searches left this month | for more free features.

Novantrone

Showing 1 - 25 of 73

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 21, 2023

Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Gilteritinib 40 MG Oral Tablet
  • +4 more
  • Lexington, Kentucky
    University of Kentucky
Oct 27, 2022

Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level

Not yet recruiting
  • Relapsed Adult AML
  • Refractory AML
  • Navitoclax Dose Level -1
  • +10 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023

Prostate Cancer Patients Trial in Qingdao, Shanghai (Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin)

Recruiting
  • Prostate Cancer Patients
  • Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin
  • Qingdao, Shandong, China
  • +1 more
May 3, 2022

Non-Hodgkins Lymphoma Trial in Fort Myers, Nashville (Cyclophosphamide, Mitoxantrone, Vincristine)

Completed
  • Non-Hodgkins Lymphoma
  • Fort Myers, Florida
  • +1 more
Feb 21, 2022

Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,

Completed
  • Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood B-Lymphoblastic Lymphoma
  • San Diego, California
  • +2 more
Sep 13, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Valhalla, New York
  • +1 more
Oct 29, 2021

Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 10, 2022

AML Trial in Boston (Etoposide, Cytarabine, Lenalidomide)

Active, not recruiting
  • AML
  • Boston, Massachusetts
  • +2 more
Jan 13, 2021

Multiple Sclerosis Trial in Isfahan (plasmapheresis)

Completed
  • Multiple Sclerosis
  • plasmapheresis
  • Isfahan, Iran, Islamic Republic of
    Alahra hospital
Aug 27, 2020

Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (drug, biological, other)

Completed
  • Acute Leukemia of Ambiguous Lineage
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 23, 2022

Lymphoma Trial in Houston (Fludarabine, Novantrone, Decadron)

Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 22, 2020

Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in

Recruiting
  • Recurrent Adult Acute Myeloid Leukemia
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 7, 2020

Acute Lymphoblastic Leukemia Trial in Canada, United States (ITMHA, Dexamethasone, Mitoxantrone)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Los Angeles, California
  • +17 more
Jun 6, 2022

Acute Myeloid Leukemia Trial in Houston (Crenolanib besylate, Idarubicin, Cytarabine)

Completed
  • Acute Myeloid Leukemia
  • Crenolanib besylate
  • +7 more
  • Houston, Texas
    MD Anderson Cancer Center
Jul 17, 2020

Follicular Lymphoma Trial in Houston (Bendamustine, Mitoxantrone, Rituximab)

Terminated
  • Follicular Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 1, 2020

Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia-2, High Grade Malignant Tumor Trial in

Completed
  • Blasts 10 Percent or More of Bone Marrow Nucleated Cells
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 11, 2021

Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia, Precursor T-Cell Lymphoblastic Leukemia Trial in

Terminated
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Los Angeles, California
  • +27 more
Oct 5, 2020

Neuromyelitis Optica, Myelitis, Transverse, Demyelinating Autoimmune Diseases, CNS Trial in Buffalo (Mitoxantrone)

Completed
  • Neuromyelitis Optica
  • +3 more
  • Buffalo, New York
    Baird Multiple Sclerosis Center
Dec 23, 2020

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
May 13, 2020

Acute Myeloid Leukemia, MDS Trial in Boston (Prexasertib, Mitoxantrone, Etoposide)

Terminated
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 10, 2019

Mixed Phenotype Acute Leukemia, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

Completed
  • Mixed Phenotype Acute Leukemia
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 21, 2020

Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine, Cyclophosphamide, Mitoxantrone)

Completed
  • Chronic Lymphocytic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 18, 2019

Acute Biphenotypic Leukemia, de Novo Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome Trial in Seattle

Completed
  • Acute Biphenotypic Leukemia
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 26, 2019

Childhood Acute Promyelocytic Leukemia (M3), Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Trial in

Active, not recruiting
  • Childhood Acute Promyelocytic Leukemia (M3)
  • Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
  • arsenic trioxide
  • +7 more
  • Birmingham, Alabama
  • +110 more
Mar 23, 2022